FMS

Fresenius Medical Care AG - Depositary Receipt (FMS) | Rumor.io

Fresenius Medical Care

FMS

Attention (50-day avg)0%

Attention rank (50-day avg)#3,334

Bullish sentiment (50-day avg)95%

Price to earnings ratio12.2

Market capitalization12.2B

Earnings per share1.89

Dividend yield (TTM)15.7%

Revenue (annual)19.6B

Net income (annual)1.2B

Social

What share of all stock conversation is about FMS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% +0

May 22

Fresenius Medical Care's stock is mentioned alongside IBM and Take-Two Interactive in a list of company names.
The company's stock price is not explicitly mentioned.
No specific news or events related to Fresenius Medical Care are mentioned in the post.

Generated by AI

Sentiment

Of the messages about FMS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	56.52% -33.32
Bearish	—	—	—	43.48% +33.32

Bullish· Nov 2

Fresenius Medical Care AG & Co. KGaA reports profit increase, reaffirming its outlook.
Strong earnings suggest the company's financial health is stable and improving.
Positive outlook indicates potential for future growth and success.

Bearish· Nov 21

Fresenius Medical Care's cash levels have dropped to 3.7%, a level that has historically preceded a decline in the stock price.
According to Bank of America market research, a cash level of 3.7% or lower has occurred 20 times since 2002, and in each case, the stock price fell and Treasury yields outperformed.
The market's euphoria and hedge fund overextension may have contributed to the recent dip, but it is likely to be a short-term issue rather than a prolonged one.

Generated by AI

Topics

Of the messages about FMS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	100%	100%	7.24%
Earnings	0%	0%	0%	2.64%
Macro	0%	0%	0%	89.71%
Analysts	0%	0%	0%	0.34%
Controversies	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	0.07%

Earnings· Jul 31

Fresenius Medical Care AG & Co. KGaA ($FMS) misses earnings estimates by $0.06 EPS.
The company reports $4.21 billion in revenue, missing estimates.
$FMS reaffirms its targets despite missing earnings estimates.

Announcements· Dec 22

Fresenius Medical Care AG & Co. KGaA has appointed NxStage as its USA sales/distribution partner for SeaStar.
$FMS will continue to produce SeaStar and serve as the sales/distribution partner for the rest of the world.
NxStage will handle sales and distribution of SeaStar in the USA, while $FMS remains the producer.

Generated by AI

Community

Of the messages about FMS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	66.67%	15.5%
Newcomers	0%	0%	33.33%	84.5%

Regulars· Feb 22

Fresenius Medical Care AG & Co. KGaA's shares gap up to $19.98, and the company's Q4 revenue grows, but it also plans restructuring and sees "headwinds" in FY23.
The company's Q4 earnings are up 7.50% in the pre-market, and the SEC Form 20-F filed by Fresenius Medical Care AG includes its 2022 FY Earnings.
Fresenius Medical Care AG & Co. KGaA's Q4 revenue grows, but the company also faces "headwinds" in FY23, according to its Q4 2022 Earnings Call Transcript.

Newcomers· May 22

Many newcomers are discussing Fresenius Medical Care's stock, wondering if it's a good time to buy or sell.
Some newcomers are focusing on the company's fundamentals, asking about its financial performance and growth prospects.
Others are discussing the potential impact of regulatory changes on Fresenius Medical Care's business operations.

Generated by AI

News

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

FMS refines its China strategy around advanced dialysis and critical-care technologies, with 110M euros in one-time costs.

22h agoYahoo Finance

Berenberg downgrades Fresenius Medical Care stock rating to hold

1d agoInvesting.com

Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Fresenius Medical Care (NYSE:

Fresenius Medical Care updates China strategy, and incurs a 110 million euro charge while focusing on advanced dialysis tech.

4d agoBenzinga

Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business

Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to

4d agoYahoo Finance

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

The U.S. Food and Drug Administration (FDA) on Tuesday issued a warning letter to Fresenius Medical Care AG & Co. KGaA’s Fresenius USA Manufacturing following a March 2026 inspection at its Ogden, Utah production facility. In a letter to the...

23d agoYahoo Finance

FDA Slams Fresenius Over Leaking Dialysis Bags - Fresenius Medical Care (NYSE:FMS)

25d agobenzinga.com

Also Discussed

Investors talking about FMS also mention

#	Name	Attention
1	DaVita Inc.DVA	0%new
2	Rockwell Medical Inc.RMTI	0%new
3	Touchstone Large Company Growth ETFTLG	0%new
4	Movado Group, Inc.MOV	0%0
5	PharmaCyte Biotech, Inc.PMCB	0%0
6	LHCG - LHC Group, Inc.	——
7	CVD Equipment CorporationCVV	0%0
8	FGEN - FibroGen, Inc.	——
9	CONMED CorporationCNMD	0%new
10	Assured Guaranty Ltd.AGO	0%0

Fresenius Medical Care AG - Depositary Receipt

Healthcare
Medical Care Facilities

Fresenius Medical Care AG - Depositary Receipt is the U.S.-traded American Depositary Receipt for Fresenius Medical Care, a global healthcare company focused on renal care. Fresenius Medical Care provides dialysis products and related services for people with chronic kidney disease, supporting treatment across hospitals, clinics, and home-based care settings. Its business is organized around care delivery and care enablement, combining clinical services with the development, manufacturing, and supply of dialysis equipment, consumables, and associated technologies. The company serves healthcare providers and patients in the United States, Europe, and other international markets, making it an important participant in the kidney care ecosystem. As a depositary receipt, it offers a U.S. listing structure for investors seeking exposure to Fresenius Medical Care’s healthcare operations without directly referencing the underlying foreign share.

Website

Location

Else-Kröner-Strasse 1

Bad Homburg, 61352

Germany

Social

What share of all stock conversation is about FMS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% +0

May 22

Fresenius Medical Care's stock is mentioned alongside IBM and Take-Two Interactive in a list of company names.
The company's stock price is not explicitly mentioned.
No specific news or events related to Fresenius Medical Care are mentioned in the post.

Generated by AI

Sentiment

Of the messages about FMS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	56.52% -33.32
Bearish	—	—	—	43.48% +33.32

Bullish· Nov 2

Fresenius Medical Care AG & Co. KGaA reports profit increase, reaffirming its outlook.
Strong earnings suggest the company's financial health is stable and improving.
Positive outlook indicates potential for future growth and success.

Bearish· Nov 21

Fresenius Medical Care's cash levels have dropped to 3.7%, a level that has historically preceded a decline in the stock price.
According to Bank of America market research, a cash level of 3.7% or lower has occurred 20 times since 2002, and in each case, the stock price fell and Treasury yields outperformed.
The market's euphoria and hedge fund overextension may have contributed to the recent dip, but it is likely to be a short-term issue rather than a prolonged one.

Generated by AI

Topics

Of the messages about FMS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	100%	100%	7.24%
Earnings	0%	0%	0%	2.64%
Macro	0%	0%	0%	89.71%
Analysts	0%	0%	0%	0.34%
Controversies	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	0.07%

Earnings· Jul 31

Fresenius Medical Care AG & Co. KGaA ($FMS) misses earnings estimates by $0.06 EPS.
The company reports $4.21 billion in revenue, missing estimates.
$FMS reaffirms its targets despite missing earnings estimates.

Announcements· Dec 22

Fresenius Medical Care AG & Co. KGaA has appointed NxStage as its USA sales/distribution partner for SeaStar.
$FMS will continue to produce SeaStar and serve as the sales/distribution partner for the rest of the world.
NxStage will handle sales and distribution of SeaStar in the USA, while $FMS remains the producer.

Generated by AI

Community

Of the messages about FMS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	66.67%	15.5%
Newcomers	0%	0%	33.33%	84.5%

Regulars· Feb 22

Fresenius Medical Care AG & Co. KGaA's shares gap up to $19.98, and the company's Q4 revenue grows, but it also plans restructuring and sees "headwinds" in FY23.
The company's Q4 earnings are up 7.50% in the pre-market, and the SEC Form 20-F filed by Fresenius Medical Care AG includes its 2022 FY Earnings.
Fresenius Medical Care AG & Co. KGaA's Q4 revenue grows, but the company also faces "headwinds" in FY23, according to its Q4 2022 Earnings Call Transcript.

Newcomers· May 22

Many newcomers are discussing Fresenius Medical Care's stock, wondering if it's a good time to buy or sell.
Some newcomers are focusing on the company's fundamentals, asking about its financial performance and growth prospects.
Others are discussing the potential impact of regulatory changes on Fresenius Medical Care's business operations.

Generated by AI

Fresenius Medical Care

Social

May 22

Bullish· Nov 2

Bearish· Nov 21

Earnings· Jul 31

Announcements· Dec 22

Regulars· Feb 22

Newcomers· May 22

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

Berenberg downgrades Fresenius Medical Care stock rating to hold

Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Fresenius Medical Care (NYSE:

Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

FDA Slams Fresenius Over Leaking Dialysis Bags - Fresenius Medical Care (NYSE:FMS)

Also Discussed

Fresenius Medical Care AG - Depositary Receipt

Company Information

Location

Social

May 22

Bullish· Nov 2

Bearish· Nov 21

Earnings· Jul 31

Announcements· Dec 22

Regulars· Feb 22

Newcomers· May 22

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

Berenberg downgrades Fresenius Medical Care stock rating to hold

Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Fresenius Medical Care (NYSE:

Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

FDA Slams Fresenius Over Leaking Dialysis Bags - Fresenius Medical Care (NYSE:FMS)

Also Discussed